Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 69

Results For "science"

2023 News Found

Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg
Drug Approval | March 19, 2025

Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer


Strides Pharma global to acquire 100% stake in Amextel
News | March 17, 2025

Strides Pharma global to acquire 100% stake in Amextel

Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products


Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg
Drug Approval | March 17, 2025

Zydus receives final approval from USFDA for Eluxadoline Tablets, 75 mg and 100 mg

Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea


OneSource Specialty Pharma strengthens its board by appointing new directors
People | March 13, 2025

OneSource Specialty Pharma strengthens its board by appointing new directors

These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance


Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram
Drug Approval | March 13, 2025

Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram

Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections


Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease
News | March 13, 2025

Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD


Zydus to acquire majority stake in Amplitude Surgical, France
News | March 12, 2025

Zydus to acquire majority stake in Amplitude Surgical, France

Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies


Syngene acquires first US biologics facility for $36.5 million
News | March 11, 2025

Syngene acquires first US biologics facility for $36.5 million

Overall investment in the US facility is estimated around US$50 million


Emcure partners with Vidya Balan for Arth supplements,
News | March 11, 2025

Emcure partners with Vidya Balan for Arth supplements,

Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues


Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
News | March 10, 2025

Astellas and YASKAWA to establish JV focused on cell therapy manufacturing

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients